Aclarion, Inc. (ACON) vs Cardio Diagnostics Holdings, Inc. (CDIO)
A side-by-side comparison of Aclarion, Inc. and Cardio Diagnostics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACON
Aclarion, Inc.
$2.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CDIO
Cardio Diagnostics Holdings, Inc.
$2.06HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACON vs CDIO
growth of $100 · dividends reinvested · last 4yACON -100.0% (-95.1%/yr)CDIO -99.3% (-71.2%/yr)CDIO compounded faster over this window
Log scale — wide-divergence pair
ACON CDIO
ACON vs CDIO: by the numbers
- •ACON is the larger company ($7M vs $6M market cap).
- •Both run net losses; ACON's is the smaller (-10978.48% vs -44771.83% net margin).
Metrics side by side
Valuation
| Metric | ACON | CDIO |
|---|---|---|
| P/S ratio | 80.52 | 421.90 |
| P/B ratio | 0.40 | 0.82 |
Profitability
| Metric | ACON | CDIO |
|---|---|---|
| Gross margin | -291.27% | 100.00% |
| Operating margin | -9312.55% | -43737.46% |
| Net margin | -10978.48% | -44771.83% |
| ROE | -54.09% | -87.12% |
| ROIC | -57.11% | -82.84% |
Growth (annualized)
| Metric | ACON | CDIO |
|---|---|---|
| Revenue CAGR (5Y) | 3.75% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.